SCHEMBL13212911

SCHEMBL13212911

CC(C)=CC(=O)N1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ LMNA P02545 2/20 0.41
▸ LTB4R Q15722 1/20 0.40
▸ LTB4R2 Q9NPC1 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MMP1 P03956 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22825659 0.98 LMNA (0.42) ALDH1A1LMNALTB4RLTB4R2USP2
SCHEMBL29842192 0.93 LMNA (0.42) ALDH1A1LMNALTB4RLTB4R2MEN1
SCHEMBL18603087 0.81 LTB4R (0.40) ALDH1A1LMNALTB4RLTB4R2USP2
SCHEMBL26880817 0.79 CYP1A2 (0.56) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL19609971 0.79 ALDH1A1 (0.38) ALDH1A1LMNALTB4RLTB4R2USP2
SCHEMBL13212895 0.77 LMNA (0.62) ALDH1A1LMNAUSP2MEN1KMT2A
SCHEMBL26880353 0.77 ALDH1A1 (0.48) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL4005530 0.77 CA2 (0.45) LMNAMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL21004727 0.77 ALDH1A1 (0.37) ALDH1A1LMNALTB4RLTB4R2USP2
SCHEMBL15821676 0.76 LMNA (0.39) LMNAMEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020253762-A1 INDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 江苏恒瑞医药股份有限公司 2020-12-24 — — WO disclosed
US-20100210652-A1 Method For Controlling Fungal Pests BASF SE (DE) 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210652-A1 Method For Controlling Fungal Pests CBR3, CAT, CYCS ALDH1A1 2074/4885LMNA 1516/4885LTB4R 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback